We drive innovative research worldwide and promote public awareness about Alzheimer's disease, risk factors, treatments, and coping strategies.
Alzheimer's Disease Research (BrightFocus Foundation)
The goal of Alzheimer's Disease Research is to advance groundbreaking research to better understand, treat, and prevent Alzheimer's disease. We are committed to providing initial funding for cutting-edge experimental ideas. We ensure the high quality of the research we fund through a rigorous, peer-review vetting process, which involves world-class, renowned scientists and clinicians. Our scientific review committees enable us to identify and support newly emerging scientists with the most promising ideas. Two of our former grantees, Paul A. Greengard and Stanley B. Pruisner, have gone on to receive Nobel Prizes for advancing understanding of the human brain and Alzheimer's disease.
Along with funding cutting-edge research, we also offer free educational materials to patients and families. Alzheimer's Disease Research provides news and research results to millions of people each year through multiple media formats and live, expert-led educational events.
We are committed to transparency and fiscal responsibility. We comply with important industry standards for charity accountability, including certification from the Better Business Bureau Wise Giving Alliance, the Maryland Nonprofit Standards for Excellence, the GuideStar Exchange Gold Seal, and HONcode standards for providing trustworthy health information.
Alzheimer's Disease Research is convinced that the best way to fight this disease is through scientific research, and we are devoted to funding the highest quality of work in the battle against Alzheimer's disease. We thank you for the opportunity to share our mission with you, and we hope that you will agree that an investment in Alzheimer's Disease Research will provide hope for better treatments and a cure for the millions of patients and family members impacted by Alzheimer's disease.